|
Name |
(-)-gamma-Cadinene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(1R,4aS,8aS)-7-methyl-4-methylidene-1-propan-2-yl-2,3,4a,5,6,8a-hexahydro-1H-naphthalene
|
|
SMILES |
CC1=C[C@H]2[C@H](CC1)C(=C)CC[C@@H]2C(C)C
|
|
InChI |
InChI=1S/C15H24/c1-10(2)13-8-6-12(4)14-7-5-11(3)9-15(13)14/h9-10,13-15H,4-8H2,1-3H3/t13-,14-,15-/m1/s1
|
|
InChIKey |
WRHGORWNJGOVQY-RBSFLKMASA-N
|
|
Synonyms |
(-)-gamma-cadinene; GAMMA-CADINENE; 1460-97-5; 2GHT32E0JU; 39029-41-9; gamma-Cadinene, (-)-; (1R,4aS,8aS)-7-methyl-4-methylidene-1-(propan-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; UNII-2GHT32E0JU; g-Cadinene; D-g-Cadinene; (+)-g-Cadinene; (?)-gamma-Cadinene; Racemic gamma Cadinene; trans- .gamma.-Cadinene; CHEBI:63203; DTXSID301017689; .GAMMA.-CADINENE, (-)-; CADINENE, .GAMMA.-, (-)-; (1R,4aS,8aS)-7-methyl-4-methylidene-1-propan-2-yl-2,3,4a,5,6,8a-hexahydro-1H-naphthalene; C19738; 1BETA,6ALPHA,7BETAH-CADINA-4,10(15)-DIENE; Q27132466; 1.BETA.,6.ALPHA.,7.BETA.H-CADINA-4,10(15)-DIENE; [1R,(-)]-1,2,3,4,4aalpha,5,6,8abeta-Octahydro-7-methyl-4-methylene-1-isopropylnaphthalene; 1,2,3,4,4a,5,6,8a-Octahydro-7-methyl-4-methylene-1-(1-methylethyl)-(1S,4aR,8aR)-Naphthalene; Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-7-methyl-4-methylene-1-(1-methylethyl)-, (1alpha,4abeta,8aalpha)-
|
|
CAS | 1460-97-5 | |
PubChem CID | 92313 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.524 |
Caco-2 Permeability: | -4.449 | MDCK Permeability: | 0.00001600 |
Pgp-inhibitor: | 0.085 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.813 |
30% Bioavailability (F30%): | 0.054 |
Blood-Brain-Barrier Penetration (BBB): | 0.189 | Plasma Protein Binding (PPB): | 94.60% |
Volume Distribution (VD): | 2.702 | Fu: | 3.30% |
CYP1A2-inhibitor: | 0.867 | CYP1A2-substrate: | 0.654 |
CYP2C19-inhibitor: | 0.424 | CYP2C19-substrate: | 0.924 |
CYP2C9-inhibitor: | 0.615 | CYP2C9-substrate: | 0.385 |
CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.209 |
CYP3A4-inhibitor: | 0.295 | CYP3A4-substrate: | 0.521 |
Clearance (CL): | 7.002 | Half-life (T1/2): | 0.152 |
hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.248 |
Drug-inuced Liver Injury (DILI): | 0.549 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.1 | Maximum Recommended Daily Dose: | 0.067 |
Skin Sensitization: | 0.042 | Carcinogencity: | 0.084 |
Eye Corrosion: | 0.052 | Eye Irritation: | 0.37 |
Respiratory Toxicity: | 0.224 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002227 | 1.000 | D04CSZ | 0.321 | ||||
ENC004008 | 0.673 | D02KIU | 0.227 | ||||
ENC002223 | 0.577 | D0V2JK | 0.223 | ||||
ENC002224 | 0.577 | D04ATM | 0.222 | ||||
ENC000831 | 0.577 | D0K5WS | 0.214 | ||||
ENC002017 | 0.527 | D0A2AJ | 0.213 | ||||
ENC000762 | 0.489 | D04GJN | 0.211 | ||||
ENC000763 | 0.489 | D06JPB | 0.210 | ||||
ENC002199 | 0.464 | D00YWP | 0.210 | ||||
ENC000339 | 0.464 | D0O1UZ | 0.209 |